Mitochondrial abnormalities in neuroectodermal cells stably expressing human amyloid precursor protein (hAPP751).

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Metabolic hypofunction is a hallmark of neurodegenerative diseases like Alzheimer's disease (AD).
• The amyloid precursor protein (APP) is strongly linked to AD pathogenesis.
• Mitochondrial dysfunction is increasingly recognized as a critical factor in neurodegeneration.

Purpose of the Study:

• To investigate the impact of amyloid precursor protein (APP) overexpression on cellular mitochondria.
• To determine if APP affects mitochondrial morphology and function in central nervous system (CNS)-type cells.
• To explore the early cellular events contributing to Alzheimer's disease pathophysiology.

Main Methods:

• Stable transfection of P19 cells with human APP751.
• Culturing neuroectodermal progeny of transfected P19 cells.
• Microscopic analysis of mitochondrial morphology.
• Assessment of mitochondrial membrane potential using established assays.

Main Results:

• APP overexpression in P19 cell progeny resulted in abnormal mitochondrial morphology.
• Mitochondria in APP-transfected cells exhibited a decreased mitochondrial membrane potential.
• Observed mitochondrial changes were independent of amyloid-beta (Abeta) toxicity.
• These alterations were distinct from complex I inhibition, suggesting a direct effect of APP.

Conclusions:

• Amyloid precursor protein (APP) overexpression directly impacts mitochondrial structure and function.
• Early mitochondrial dysfunction, preceding Abeta toxicity, may play a role in Alzheimer's disease.
• These findings offer insights into the earliest pathological events in AD and potential therapeutic targets.